Gene dosage-dependent effects of bcl-2 expression on cellular survival and redox status

Free Radical Biology and Medicine

Volumn 34, Issue 12, 2003, Pages 1517-1530

  Seyfried, Jan ^a,c   Evert, Bernd O ^a   Schwarz, Cordelia S ^a   Schaupp, Matthias ^b   Schulz, Jörg B ^b   Klockgether, Thomas ^a   Wüllner, Ullrich ^a  

^a UNIVERSITY OF BONN   (Germany)

^b UNIVERSITY OF TÜBINGEN   (Germany)

^c UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Antioxidant; Apoptosis; Bcl 2; Free radicals; Glutathione; Neurodegeneration; Oxidative stress; PC 12 cells

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; DOPAMINE; GLUTATHIONE; LEVODOPA; PROTEIN BCL 2;

ANIMAL CELL; ANTIOXIDANT ACTIVITY; ARTICLE; CELL CYCLE; CELL GROWTH; CELL STRAIN; CELL SURVIVAL; CONCENTRATION RESPONSE; CONTROLLED STUDY; EMBRYO; ENZYME ACTIVATION; ENZYME INHIBITION; GENE DOSAGE; GENE EXPRESSION; GENE FUNCTION; GENE INDUCTION; GENE OVEREXPRESSION; GROWTH INHIBITION; HUMAN; HUMAN CELL; NEUROTOXICITY; NONHUMAN; OXIDATION REDUCTION STATE; OXIDATIVE STRESS; PHEOCHROMOCYTOMA CELL; PRIORITY JOURNAL; RAT; SENSITIZATION;

EID: 0038697956     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0891-5849(03)00103-5     Document Type: Article

References (57)

1. Adams J.M., Cory S. The bcl-2 protein family arbiters of cell survival. Science. 281:1998;1322-1326.
2. Sedlak T.W., Oltvai Z.N., Yang E., Wang K., Boise L.H., Thompson C.B., Korsmeyer S.J. Multiple bcl-2 family members demonstrate selective dimerizations with Bax. Proc. Natl. Acad. Sci. USA. 92:1995;7834-7838.
3. Akao Y., Otsuki Y., Kataoka S., Ito Y., Tsujimoto Y. Multiple subcellular localization of bcl-2 detection in nuclear outer membrane, endoplasmic reticulum membrane, and mitochondrial membranes. Cancer Res. 54:1994;2468-2471.
4. Krajewski S., Tanaka S., Takayama S., Schibler M.J., Fenton W., Reed J.C. Investigation of the subcellular distribution of the bcl-2 oncoprotein residence in the nuclear envelope, endoplasmic reticulum, and outer mitochondrial membranes. Cancer Res. 53:1993;4701-4714.
5. Yang J., Liu X., Bhalla K., Kim C.N., Ibrado A.M., Cai J., Peng T.I., Jones D.P., Wang X. Prevention of apoptosis by bcl-2 release of cytochrome c from mitochondria blocked. Science. 275:1997;1129-1132.
6. Kluck R.M., Bossy-Wetzel E., Green D.R., Newmeyer D.D. The release of cytochrome c from mitochondria a primary site for bcl-2 regulation of apoptosis. Science. 275:1997;1132-1136.
7. Nguyen M., Branton P.E., Walton P.A., Oltvai Z.N., Korsmeyer S.J., Shore G.C. Role of membrane anchor domain of bcl-2 in suppression of apoptosis caused by E1B-defective adenovirus. J. Biol. Chem. 269:1994;16521-16524.
8. Voehringer D.W., Meyn R.E. Redox aspects of bcl-2 function. Antioxid. Redox Signal. 2:2000;537-550.
9. Kane D.J., Sarafian T.A., Anton R., Hahn H., Gralla E.B., Valentine J.S., Ord T., Bredesen D.E. Bcl-2 inhibition of neural death decreased generation of reactive oxygen species. Science. 262:1993;1274-1277.
10. Hockenbery D.M., Oltvai Z.N., Yin X.M., Milliman C.L., Korsmeyer S.J. Bcl-2 functions in an antioxidant pathway to prevent apoptosis. Cell. 75:1993;241-251.
11. Tyurin V.A., Tyurina Y.Y., Quinn P.J., Schor N.F., Balachandran R., Day B.W., Kagan V.E. Glutamate-induced cytotoxicity in PC12 pheochromocytoma cells role of oxidation of phospholipids, glutathione, and protein sulfhydryls revealed by bcl-2 transfection. Brain Res. Mol. Brain Res. 60:1998;270-281.
12. Ellerby L.M., Ellerby H.M., Park S.M., Holleran A.L., Murphy A.N., Fiskum G., Kane D.J., Testa M.P., Kayalar C., Bredesen D.E. Shift of the cellular oxidation-reduction potential in neural cells expressing bcl-2. J. Neurochem. 67:1996;1259-1267.
13. Voehringer D.W. Bcl-2 and glutathione alterations in cellular redox state that regulate apoptosis sensitivity. Free Radic. Biol. Med. 27:1999;945-950.
14. Esposti M.D., Hatzinisiriou I., McLennan H., Ralph S. Bcl-2 and mitochondrial oxygen radicals. New approaches with reactive oxygen species-sensitive probes. J. Biol. Chem. 274:1999;29831-29837.
15. Steinman H.M. The bcl-2 oncoprotein functions as a pro-oxidant. J. Biol. Chem. 270:1995;3487-3490.
16. Thompson C.B. Apoptosis in the pathogenesis and treatment of disease. Science. 267:1995;1456-1462.
17. Schulz J.B., Lindenau J., Seyfried J., Dichgans J. Glutathione, oxidative stress, and neurodegeneration. Eur. J. Biochem. 267:2000;4904-4911.
18. Stefanis L., Burke R.E., Greene L.A. Apoptosis in neurodegenerative disorders. Curr. Opin. Neurol. 10:1997;299-305.
19. Beal M.F. Aging, energy, and oxidative stress in neurodegenerative diseases. Ann. Neurol. 38:1995;357-366.
20. Jenner P., Dexter D.T., Sian J., Schapira A.H., Marsden C.D. Oxidative stress as a cause of nigral cell death in Parkinson's disease and incidental Lewy body disease. The Royal Kings and Queens Parkinson's Disease Research Group. Ann. Neurol. 32:(Suppl.):1992;S82-S87.
21. Wüllner U., Kornhuber J., Weller M., Schulz J.B., Loschmann P.A., Riederer P., Klockgether T. Cell death and apoptosis-regulating proteins in Parkinson's disease a cautionary note. Acta Neuropathol. (Berl). 97:1999;408-412.
22. Hartmann A., Hunot S., Michel P.P., Muriel M.P., Vyas S., Faucheux B.A., Mouatt-Prigent A., Turmel H., Srinivasan A., Ruberg M., Evan G.I., Agid Y., Hirsch E.C. Caspase-3 a vulnerability factor and final effector in apoptotic death of dopaminergic neurons in Parkinson's disease. Proc. Natl. Acad. Sci. USA. 97:2000;2875-2880.
23. Anton R., Kordower J.H., Kane D.J., Markham C.H., Bredesen D.E. Neural transplantation of cells expressing the antiapoptotic gene bcl-2. Cell Transplant. 4:1995;49-54.
24. Lud Cadet J., Harrington B., Ordonez S. Bcl-2 overexpression attenuates dopamine-induced apoptosis in an immortalized neural cell line by suppressing the production of reactive oxygen species. Synapse. 35:2000;228-233.
25. Yang L., Matthews R.T., Schulz J.B., Klockgether T., Liao A.W., Martinou J.C., Penney J.B. Jr, Hyman B.T., Beal M.F. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyride neurotoxicity is attenuated in mice overexpressing bcl-2. J. Neurosci. 18:1998;8145-8152.
26. Yamada M., Oligino T., Mata M., Goss J.R., Glorioso J.C., Fink D.J. Herpes simplex virus vector-mediated expression of bcl-2 prevents 6-hydroxydopamine-induced degeneration of neurons in the substantia nigra in vivo. Proc. Natl. Acad. Sci. USA. 96:1999;4078-4083.
27. Schwarz C.S., Evert B.O., Seyfried J., Schaupp M., Kunz W.S., Vielhaber S., Klockgether T., Wüllner U. Overexpression of bcl-2 results in reduction of cytochrome c content and inhibition of complex I activity. Biochem. Biophys. Res. Commun. 280:2001;1021-1027.
28. Gossen M., Bujard H. Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc. Natl. Acad. Sci. USA. 89:1992;5547-5551.
29. Greene L.A., Tischler A.S. Establishment of a noradrenergic clonal line of rat adrenal pheochromocytoma cells which respond to nerve growth factor. Proc. Natl. Acad. Sci. USA. 73:1976;2424-2428.
30. Soldner F., Weller M., Haid S., Beinroth S., Miller S.W., Wüllner U., Davis R.E., Dichgans J., Klockgether T., Schulz J.B. MPP+ inhibits proliferation of PC12 cells by a p21(WAF1/Cip1)-dependent pathway and induces cell death in cells lacking p21(WAF1/Cip1). Exp. Cell. Res. 250:1999;75-85.
31. Seyfried J., Soldner F., Schulz J.B., Klockgether T., Kovar K.A., Wüllner U. Differential effects of L-buthionine sulfoximine and ethacrynic acid on glutathione levels and mitochondrial function in PC12 cells. Neurosci. Lett. 264:1999;1-4.
32. Tietze F. Enzymic method for quantitative determination of nanogram amounts of total and oxidized glutathione applications to mammalian blood and other tissues. Anal. Biochem. 27:1969;502-522.
33. Baker M.A., Cerniglia G.J., Zaman A. Microtiter plate assay for the measurement of glutathione and glutathione disulfide in large numbers of biological samples. Anal. Biochem. 190:1990;360-365.
34. Lowry, O. H.; Rosebrough, N. J.; Farr, A. L.; Randall, R. J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193:265-275; 1951.
35. LeBel C.P., Ischiropoulos H., Bondy S.C. Evaluation of the probe 2′,7′-dichlorofluorescin as an indicator of reactive oxygen species formation and oxidative stress. Chem. Res. Toxicol. 5:1992;227-231.
36. Gossen M., Freundlieb S., Bender G., Muller G., Hillen W., Bujard H. Transcriptional activation by tetracyclines in mammalian cells. Science. 268:1995;1766-1769.
37. Seyfried J., Evert B.O., Rundfeldt C., Schulz J.B., Kovar K.A., Klockgether T., Wüllner U. Flupirtine and retigabine prevent L-glutamate toxicity in rat pheochromocytoma PC 12 cells. Eur. J. Pharmacol. 400:2000;155-166.
38. Walkinshaw G., Waters C.M. Induction of apoptosis in catecholaminergic PC12 cells by L-DOPA. Implications for the treatment of Parkinson's disease. J. Clin. Invest. 95:1995;2458-2464.
39. Meister A., Anderson M.E. Glutathione. Annu. Rev. Biochem. 52:1983;711-760.
40. Schor N.F., Rudin C.M., Hartman A.R., Thompson C.B., Tyurina Y.Y., Kagan V.E. Cell line dependence of bcl-2-induced alteration of glutathione handling. Oncogene. 19:2000;472-476.
41. Reber U., Wüllner U., Trepel M., Baumgart J., Seyfried J., Klockgether T., Dichgans J., Weller M. Potentiation of treosulfan toxicity by the glutathione-depleting agent buthionine sulfoximine in human malignant glioma cells the role of bcl-2. Biochem. Pharmacol. 55:1998;349-359.
42. Xia Z., Dickens M., Raingeaud J., Davis R.J., Greenberg M.E. Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science. 270:1995;1326-1331.
43. Chakraborti S., Chakraborti T. Oxidant-mediated activation of mitogen-activated protein kinases and nuclear transcription factors in the cardiovascular system a brief overview. Cell. Signal. 10:1998;675-683.
44. Deora A.A., Win T., Vanhaesebroeck B., Lander H.M. A redox-triggered ras-effector interaction. Recruitment of phosphatidylinositol 3′-kinase to ras by redox stress. J. Biol. Chem. 273:1998;29923-29928.
45. Schwarz C.S., Seyfried J., Evert B.O., Klockgether T., Wüllner U. Bcl-2 upregulates ha-ras mRNA expression and induces c-Jun phosphorylation at Ser73 via an ERK-dependent pathway in PC 12 cells. Neuroreport. 13:(18):2002;2439-2442.
46. Pang L., Sawada T., Decker S.J., Saltiel A.R. Inhibition of MAP kinase kinase blocks the differentiation of PC-12 cells induced by nerve growth factor. J. Biol. Chem. 270:1995;13585-13588.
47. Evert B.O., Wüllner U., Schulz J.B., Weller M., Groscurth P., Trottier Y., Brice A., Klockgether T. High-level expression of expanded full-length ataxin-3 in vitro causes cell death and formation of intranuclear inclusions in neuronal cells. Hum. Mol. Genet. 8:1999;1169-1176.
48. Uhlmann E.J., Subramanian T., Vater C.A., Lutz R., Chinnadurai G. A potent cell death activity associated with transient high-level expression of bcl-2. J. Biol. Chem. 273:1998;17926-17932.
49. Vairo G., Soos T.J., Upton T.M., Zalvide J., DeCaprio J.A., Ewen M.E., Koff A., Adams J.M. Bcl-2 retards cell cycle entry through p27(Kip1), pRB relative p130, and altered E2F regulation. Mol. Cell. Biol. 20:2000;4745-4753.
50. Gao G., Dou Q.P. G(1) phase-dependent expression of bcl-2 mRNA and protein correlates with chemoresistance of human cancer cells. Mol. Pharmacol. 58:2000;1001-1010.
51. Meredith M.J., Reed D.J. Status of the mitochondrial pool of glutathione in the isolated hepatocyte. J. Biol. Chem. 257:1982;3747-3753.
52. Voehringer D.W., McConkey D.J., McDonnell T.J., Brisbay S., Meyn R.E. Bcl-2 expression causes redistribution of glutathione to the nucleus. Proc. Natl. Acad. Sci. USA. 95:1998;2956-2960.
53. Seyfried J., Soldner F., Kunz W.S., Schulz J.B., Klockgether T., Kovar K.A., Wüllner U. Effect of 1-methyl-4-phenylpyridinium on glutathione in rat pheochromocytoma PC 12 cells. Neurochem. Int. 36:2000;489-497.
54. Balijepalli S., Annepu J., Boyd M.R., Ravindranath V. Effect of thiol modification on brain mitochondrial complex I activity. Neurosci. Lett. 272:1999;203-206.
55. Jha N., Jurma O., Lalli G., Liu Y., Pettus E.H., Greenamyre J.T., Liu R.M., Forman H.J., Andersen J.K. Glutathione depletion in PC12 results in selective inhibition of mitochondrial complex I activity. Implications for Parkinson's disease. J. Biol. Chem. 275:2000;26096-26101.
56. de la Asuncion J.G., Millan A., Pla R., Bruseghini L., Esteras A., Pallardo F.V., Sastre J., Vina J. Mitochondrial glutathione oxidation correlates with age-associated oxidative damage to mitochondrial DNA. FASEB J. 10:1996;333-338.
57. Suter M., Richter C. Fragmented mitochondrial DNA is the predominant carrier of oxidized DNA bases. Biochemistry. 38:1999;459-464.